VKVivien Kmietczyk

Vivien Kmietczyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vivien Kmietczyk has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Mirko Völkers

    Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

    4 shared publications
  • Verena Kamuf-Schenk

    3 shared publications
  • Christoph Hofmann

    Department of Internal Medicine III (Cardiology, Angiology, and Pneumology [C.H., A.S., O.M.S., J.F., F. Sicklinger, F.S.Y., I.S.M., E.M., C. Sandmann, L.J., V.K.-S., C. Stroh, Z.L., D.F., E.B., H.A.K., N.F., F.L., M.V.]), Heidelberg University Hospital, Germany

    2 shared publications
  • Ellen Malovrh

    Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), Heidelberg University Hospital, 69120 Heidelberg, Germany

    2 shared publications
  • Eshita Varma

    Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), Heidelberg University Hospital

    2 shared publications
  • Etienne Boileau

    Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), University Hospital Heidelberg , Im Neuenheimer Feld 669, 69120 Heidelberg

    2 shared publications

Latest Publications

  • Open Access

    ZEB1 Is a Key Regulator of Cardiomyocyte Structure and Function

    by Parul Gupta, Daniel Finke, Verena Kamuf-Schenk, Anushka Deshpande, Marc P. Stemmler, Simone Brabletz, Thomas Brabletz, Norbert Frey, Tobias Jakobi, Mirko Völkers, et al.

    Background: Our previous work identified the transcription factor “Zinc Finger E-Box Binding Homeobox 1” (ZEB1) as a downstream effector of Cytoplasmic Polyadenylation Element Binding Protein 4 (CPEB4), an RNA-binding protein responsive to cardiac stress. While ZEB1 is known for its role in cancer metastasis and epithelial-to-mesenchymal transition (EMT), its function in cardiomyocytes is not well understood. Based on previous findings, we hypothesize that ZEB1 is essential for maintaining the structural integrity and mitochondrial function of cardiomyocytes. Methods: AAV9-Zeb1 was used for the overexpression of Zeb1. Using a myosin heavy chain alpha (αMHC) Cre system, we created a Zeb1 conditional knockout mouse. To evaluate cardiac function and structure, we used echocardiography, electron microscopy, immunohistochemistry. We identified differentially expressed genes following Zeb1 deletion using RNA-seq and determined direct Zeb1 target genes by integrating this transcriptome data with a Zeb1 ChIP-seq dataset. Results: ZEB1 deletion leads to sarcomere damage, mitochondrial dysfunction, and dedifferentiation, with more pronounced effects in females. Overexpression promotes hypertrophic remodeling. Echocardiographic analysis showed progressive systolic dysfunction, and histology revealed sarcomeric disarray, again especially in females. A tamoxifen-inducible ZEB1 knockout mouse model only confirmed ZEB1’s crucial role in fully differentiated cardiomyocytes in female mice. Integrated analysis of RNA-seq and ChIP-seq revealed that Zeb1 directly regulated mitochondrial genes, thereby playing a critical role cardiomyocyte energy supply and having secondary effects on cardiac structure and function. Conclusions: ZEB1 is critical for cardiomyocyte homeostasis, and maintaining its function is necessary for normal cardiac performance and structure.

  • Open Access

    Ythdf2 regulates cardiac remodeling through its m 6 A-mRNA target transcripts

    by V. Kmietczyk, J. Oelschläger, E. Varma, S. Hartl, M. Konstandin, A. Marx, P. Gupta, Z. Loewenthal, V. Kamuf-Schenk, L. Jürgensen, et al.

    M 6 A mRNA methylation controls cardiomyocyte function and increased overall m 6 A levels are a stereotyping finding in heart failure independent of the underlying etiology. However, it is largely unknown how the information is read by m 6 A reader proteins in heart failure. Here we show that the m 6 A reader protein Ythdf2 controls cardiac function and identified a novel mechanism how reader proteins control gene expression and cardiac function. Deletion of Ythdf2 in cardiomyocytes in vivo leads to cardiac hypertrophy, reduced heart function, and increased fibrosis during pressure overload as well as during aging. Similarly, in vitro the knockdown of Ythdf2 results in cardiomyocyte growth and remodeling. Mechanistically, we identified the eucaryotic elongation factor 2 as a major target of Ythdf2 using cell type specific Ribo-seq data. Our study expands our understanding on the regulatory functions of m 6 A methylation in cardiomyocytes and how cardiac function is controlled by the m 6 A reader protein Ythdf2.

  • Open Access

    Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling

    by Agnieszka A Górska, Clara Sandmann, Eva Riechert, Christoph Hofmann, Ellen Malovrh, Eshita Varma, Vivien Kmietczyk, Julie Ölschläger, Lonny Jürgensen, Verena Kamuf-Schenk, et al.

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


  • Open Access

    m6A-mRNA methylation regulates cardiac gene expression and cellular growth

    by Vivien Kmietczyk, Eva Riechert, Laura Kalinski, Etienne Boileau, Ellen Malovrh, Brandon Malone, Agnieszka Gorska, Christoph Hofmann, Eshita Varma, Lonny Jürgensen, et al.

    Conceptually similar to modifications of DNA, mRNAs undergo chemical modifications, which can affect their activity, localization, and stability. The most prevalent internal modification in mRNA is the methylation of adenosine at the N6-position (m6A). This returns mRNA to a role as a central hub of information within the cell, serving as an information carrier, modifier, and attenuator for many biological processes. Still, the precise role of internal mRNA modifications such as m6A in human and murine-dilated cardiac tissue remains unknown. Transcriptome-wide mapping of m6A in mRNA allowed us to catalog m6A targets in human and murine hearts. Increased m6A methylation was found in human cardiomyopathy. Knockdown and overexpression of the m6A writer enzyme Mettl3 affected cell size and cellular remodeling both in vitro and in vivo. Our data suggest that mRNA methylation is highly dynamic in cardiomyocytes undergoing stress and that changes in the mRNA methylome regulate translational efficiency by affecting transcript stability. Once elucidated, manipulations of methylation of specific m6A sites could be a powerful approach to prevent worsening of cardiac function.